WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, announced today the launch of the Quell
Record diabetes product revenue of $0.8M Progress with over-the-counter wearable device to treat chronic pain DPNCheck ® launch in Japan Overall year-over-year revenue growth of 9% WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO), today reported business
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it will join an exclusive number of companies to participate in CES Unveiled, the official press event of the International Consumer Electronics Show in Las Vegas in January 2015 .
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced that Quell ® Wearable Pain Relief Technology ™ will be featured at SLEEP 2016, which is a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society .
The Only FDA Cleared 24/7 Wearable for Chronic Pain Relief Without a Prescription WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell ® Wearable Pain Relief Technology ™ will be featured at the Midwest Podiatry Conference to be held March 31-April 3 at the
100% Drug Free, FDA Cleared Wearable for Widespread Relief from Chronic Pain WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell ® Wearable Pain Relief Technology™ will be featured at the Western Foot & Ankle Conference to be held June 23-26 in Anaheim, CA.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) today announced that Quell ® Wearable Pain Relief Technology ™ will be featured at the SXSW Health & MedTech Expo from March 12-13 th in Austin, Texas . SXSW attendees can learn more about the latest generation of Quell
The Only FDA Cleared 24/7 Wearable for Chronic Pain Relief WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced that Quell Wearable Pain Relief Technology™ will be featured at the Combined Sections Meeting of the American Physical Therapy Association in Anaheim, CA
The Only FDA Cleared 24/7 Wearable for Chronic Pain Relief WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced that Quell Wearable Pain Relief Technology™ will be featured at the American Academy of Pain Medicine (AAPM) Annual Meeting in Palm Springs, California at
